View Item 

Show simple item record

Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducer
dc.contributor.authorStrong, Randy
dc.contributor.authorMiller, Richard A.
dc.contributor.authorAntebi, Adam
dc.contributor.authorAstle, Clinton M.
dc.contributor.authorBogue, Molly
dc.contributor.authorDenzel, Martin S.
dc.contributor.authorFernandez, Elizabeth
dc.contributor.authorFlurkey, Kevin
dc.contributor.authorHamilton, Karyn L.
dc.contributor.authorLamming, Dudley W.
dc.contributor.authorJavors, Martin A.
dc.contributor.authorMagalhães, João Pedro
dc.contributor.authorMartinez, Paul Anthony
dc.contributor.authorMcCord, Joe M.
dc.contributor.authorMiller, Benjamin F.
dc.contributor.authorMüller, Michael
dc.contributor.authorNelson, James F.
dc.contributor.authorNdukum, Juliet
dc.contributor.authorRainger, G. Ed.
dc.contributor.authorRichardson, Arlan
dc.contributor.authorSabatini, David M.
dc.contributor.authorSalmon, Adam B.
dc.contributor.authorSimpkins, James W.
dc.contributor.authorSteegenga, Wilma T.
dc.contributor.authorNadon, Nancy L.
dc.contributor.authorHarrison, David E.
dc.date.accessioned2016-10-17T21:17:40Z
dc.date.available2017-12-01T21:54:11Zen
dc.date.issued2016-10
dc.identifier.citationStrong, Randy; Miller, Richard A.; Antebi, Adam; Astle, Clinton M.; Bogue, Molly; Denzel, Martin S.; Fernandez, Elizabeth; Flurkey, Kevin; Hamilton, Karyn L.; Lamming, Dudley W.; Javors, Martin A.; Magalhães, João Pedro ; Martinez, Paul Anthony; McCord, Joe M.; Miller, Benjamin F.; Müller, Michael ; Nelson, James F.; Ndukum, Juliet; Rainger, G. Ed.; Richardson, Arlan; Sabatini, David M.; Salmon, Adam B.; Simpkins, James W.; Steegenga, Wilma T.; Nadon, Nancy L.; Harrison, David E. (2016). "Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducer." Aging Cell 15(5): 872-884.
dc.identifier.issn1474-9718
dc.identifier.issn1474-9726
dc.identifier.urihttps://hdl.handle.net/2027.42/134124
dc.publisherWiley Periodicals, Inc.
dc.publisherElsevier
dc.subject.otherrapamycin
dc.subject.otherUDCA
dc.subject.other17‐α‐estradiol
dc.subject.otheracarbose
dc.subject.otherfish oil
dc.subject.othermetformin
dc.subject.otherNDGA
dc.subject.otherProtandim
dc.titleLonger lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducer
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMolecular, Cellular and Developmental Biology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/134124/1/acel12496.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/134124/2/acel12496_am.pdf
dc.identifier.doi10.1111/acel.12496
dc.identifier.sourceAging Cell
dc.identifier.citedreferenceMiller RA, Harrison D, Astle CM, Baur JA, Boyd AR, de Cabo R, Fernandez E, Flurkey K, Javors MA, Nelson JF, Orihuela CJ, Pletcher S, Sharp ZD, Sinclair D, Starnes JW, Wilkinson JE, Nadon NL, Strong R ( 2011 ) Rapamycin, but not resveratrol or simvastatin, extends lifespan of genetically heterogeneous mice. J. Gerontol. A Biol. Sci. Med. Sci. 66, 191 – 201.
dc.identifier.citedreferenceAlberts DS, Martínez ME, Hess LM, Einspahr JG, Green SB, Bhattacharyya AK, Guillen J, Krutzsch M, Batta AK, Salen G, Fales L, Koonce K, Parish D, Clouser M, Roe D, Lance P, Phoenix and Tucson Gastroenterologist Networks ( 2005 ) Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. J. Natl Cancer Inst. 97, 846 – 853.
dc.identifier.citedreferenceAmador‐Noguez D, Dean A, Huang W, Setchell K, Moore D, Darlington G ( 2007 ) Alterations in xenobiotic metabolism in the long‐lived Little mice. Aging Cell 6, 453 – 470.
dc.identifier.citedreferenceAnisimov VN, Berstein LM, Egormin PA, Piskunova TS, Popovich IG, Zabezhinski MA, Kovalenko IG, Poroshina TE, Semenchenko AV, Provinciali M, Re F, Franceschi C ( 2005 ) Effect of metformin on life span and on the development of spontaneous mammary tumors in HER‐2/neu transgenic mice. Exp. Gerontol. 40, 685 – 693.
dc.identifier.citedreferenceArriola Apelo SI, Neuman JC, Baar EL, Syed FA, Cummings NE, Brar HK, Pumper CP, Kimple ME, Lamming DW ( 2016 ) Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system. Aging Cell 15, 28 – 38. doi: 10.1111/acel.12405
dc.identifier.citedreferenceBannister CA, Holden SE, Jenkins‐Jones S, Morgan CL, Halcox JP, Schernthaner G, Mukherjee J, Currie CJ ( 2014 ) Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non‐diabetic controls. Diabetes Obes. Metab. 16, 1165 – 1173.
dc.identifier.citedreferenceBogaard HJ, Natarajan R, Henderson SC, Long CS, Kraskauskas D, Smithson L, Ockaili R, McCord JM, Voelkel NF ( 2009 ) Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure. Circulation 120, 1951 – 1960.
dc.identifier.citedreferenceClark JH, Williams M, Upchurch S, Eriksson H, Helton E, Markaverich BM ( 1982 ) Effects of estradiol‐17a on nuclear occupancy of the estrogen receptor, stimulation of nuclear type II sites and uterine growth. J. Steroid Biochem. 16, 323 – 328.
dc.identifier.citedreferenceDeFronzo RA, Barzilai N, Simonson DC ( 1991 ) Mechanism of metformin action in obese and lean noninsulin‐dependent diabetic subjects. J. Clin. Endocrinol. Metab. 73, 1294 – 1301.
dc.identifier.citedreferenceDowling RJ, Zakikhani M, Fantus IG, Pollak M, Sonenberg N ( 2007 ) Metformin inhibits mammalian target of rapamycin‐dependent translation initiation in breast cancer cells. Cancer Res. 67, 10804 – 10812.
dc.identifier.citedreferenceDykens JA, Moos WH, Howell N ( 2005 ) Development of 17alpha‐estradiol as a neuroprotective therapeutic agent: rationale and results from a phase I clinical study. Ann. N. Y. Acad. Sci. 1052, 116 – 135.
dc.identifier.citedreferenceFernandes G ( 2008 ) Progress in nutritional immunology. Immunol. Res. 40, 244 – 261.
dc.identifier.citedreferenceFestuccia WT, Blanchard PG, Belchior T, Chimin P, Paschoal VA, Magdalon J, Hirabara SM, Simões D, St‐Pierre P, Carpinelli A, Marette A, Deshaies Y ( 2014 ) PPARγ activation attenuates glucose intolerance induced by mTOR inhibition with rapamycin in rats. Am. J. Physiol. Endocrinol. Metab. 306, E1046 – E1054.
dc.identifier.citedreferenceHall SS ( 2015 ) A trial for the ages. Science 349, 1274 – 1278.
dc.identifier.citedreferenceHarrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, Nadon NL, Wilkinson E, Frenkel K, Carter CS, Pahor M, Javors MA, Fernandez E, Miller RA ( 2009 ) Rapamycin fed late in life extends longevity of genetically heterogeneous mice. Nature 460, 392 – 396.
dc.identifier.citedreferenceHarrison DE, Strong R, Allison DB, Ames BN, Astle CM, Atamna H, Fernandez E, Flurkey F, Javors MA, Nadon NL, Nelson JF, Simpkins JW, Smith D, Wilkinson JE, Miller RA ( 2014 ) Acarbose, 17‐α‐estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males. Aging Cell 13, 273 – 282.
dc.identifier.citedreferenceJolly CA, Muthukumar A, Avula CP, Troyer D, Fernandes G ( 2001 ) Life span is prolonged in food‐restricted autoimmune‐prone (NZB × NZW)F(1) mice fed a diet enriched with (n‐3) fatty acids. J. Nutr. 131, 2753 – 2760.
dc.identifier.citedreferenceKris‐Etherton PM, Harris WS, Appel LJ ( 2002 ) Fish consumption, fish oil, omega‐3 fatty acids, and cardiovascular disease. Circulation 106, 2747 – 2757.
dc.identifier.citedreferenceLamming DW, Ye L, Sabatini DM, Baur JA ( 2013 ) Rapalogs and mTOR inhibitors as anti‐aging therapeutics. J. Clin. Invest. 123, 980 – 989.
dc.identifier.citedreferenceLeiser SF, Miller RA ( 2010 ) Nrf2 signaling, a mechanism for cellular stress resistance in long‐lived mice. Mol. Cell. Biol. 30, 871 – 884.
dc.identifier.citedreferenceLipman R, Galecki A, Burke DT, Miller RA ( 2004 ) Genetic loci that influence cause of death in a heterogeneous mouse stock. J. Gerontol. Biol. Sci. Med. Sci. 59, 977 – 983.
dc.identifier.citedreferenceLiu R, Wen Y, Perez E, Wang X, Day AL, Simpkins JW, Yang SH ( 2005 ) 17 β‐Estradiol attenuates blood‐brain barrier disruption induced by cerebral ischemia‐reperfusion injury in female rats. Brain Res. 1060, 55 – 61.
dc.identifier.citedreferenceLiu J, Gu X, Robbins D, Li G, Shi R, McCord JM, Zhao Y ( 2009 ) Protandim, a fundamentally new antioxidant approach in chemoprevention using mouse two‐stage skin carcinogenesis as a model. PLoS ONE 4, e5284.
dc.identifier.citedreferenceLukivskaya O, Lis R, Egorov A, Naruta E, Tauschel HD, Buko VU ( 2004 ) The protective effect of ursodeoxycholic acid in alloxan‐induced diabetes. Cell Biochem. Funct. 22, 97 – 103.
dc.identifier.citedreferencede Magalhaes JP, Cabral JA, Magalhaes D ( 2005 ) The influence of genes on the aging process of mice: a statistical assessment of the genetics of aging. Genetics 169, 265 – 274.
dc.identifier.citedreferenceMartin‐Montalvo A, Mercken EM, Mitchell SJ, Palacios HH, Mote PL, Scheibye‐Knudsen M, Gomes AP, Ward TM, Minor RK, Blouin MJ, Schwab M, Pollak M, Zhang Y, Yu Y, Becker KG, Bohr VA, Ingram DK, Sinclair DA, Wolf NS, Spindler SR, Bernier M, de Cabo R ( 2013 ) Metformin improves healthspan and lifespan in mice. Nat. Commun. 4, 2192.
dc.identifier.citedreferenceMiller RA, Chrisp C ( 2002 ) T cell subset patterns that predict resistance to spontaneous lymphoma, mammary adenocarcinoma, and fibrosarcoma in mice. J. Immunol. 169, 1619 – 1625.
dc.identifier.citedreferenceMiller RA, Harrison DE, Astle CM, Fernandez E, Flurkey K, Han M, Javors MA, Li X, Nadon NL, Nelson JF, Pletcher S, Van Roekel S, Salmon AB, Sharp ZD, Winkleman L, Strong R ( 2014 ) Rapamycin‐mediated lifespan increase in mice is dose and sex‐dependent and is metabolically distinct from dietary restriction. Aging Cell 13, 468 – 477.
dc.identifier.citedreferenceNadon NL, Miller RA, Strong R, Harrison DE ( 2016 ) NIA Interventions Testing Program: a Collaborative Approach for Investigating Interventions to Promote Healthy Aging. In Handbook of Biology of Aging, 8th edn ( Kaeberlein M, Martin GM, eds). New York: Elsevier, pp. 287 – 303.
dc.identifier.citedreferenceNathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B ( 2006 ) Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 29, 1963 – 1972.
dc.identifier.citedreferenceNelson SK, Bose SK, Grunwald GK, Myhill P, McCord JM ( 2006 ) The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy. Free Radic. Biol. Med. 40, 341 – 347.
dc.identifier.citedreferenceOnken B, Driscoll M ( 2010 ) Metformin induces a dietary restriction‐like state and the oxidative stress response to extend C. elegans healthspan via AMPK, LKB1, and SKN‐1. PLoS ONE 5, e8758.
dc.identifier.citedreferenceOyama K, Shiota G, Ito H, Murawaki Y, Kawasaki H ( 2002 ) Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats. Carcinogenesis 23, 885 – 892.
dc.identifier.citedreferencePerez E, Liu R, Yang SH, Cai ZY, Covey DF, Simpkins JW ( 2005 ) Neuroprotective effects of an estratriene analog are estrogen receptor independent in vitro and in vivo. Brain Res. 1038, 216 – 222.
dc.identifier.citedreferenceRose DP, Connolly JM ( 1999 ) Omega‐3 fatty acids as cancer chemopreventive agents. Pharmacol. Ther. 83, 217 – 244.
dc.identifier.citedreferenceSidhu KS ( 2003 ) Health benefits and potential risks related to consumption of fish or fish oil. Regul. Toxicol. Pharmacol. 38, 336 – 344.
dc.identifier.citedreferenceSmith Jr DL, Elam CF Jr, Mattison JA, Lane MA, Roth GS, Ingram DK, Allison DB ( 2010 ) Metformin supplementation and life span in Fischer‐344 rats. J. Gerontol. A Biol. Sci. Med. Sci. 65, 468 – 474.
dc.identifier.citedreferenceSpindler SR, Mote PL, Lublin AL, Flegal JM, Dhahbi JM, Li R ( 2015 ) Nordihydroguaiaretic acid extends the lifespan of drosophila and mice, Increases mortality‐related tumors and hemorrhagic diathesis, and alters energy homeostasis in mice. J. Gerontol. A Biol. Sci. Med. Sci. 70, 1479 – 1489.
dc.identifier.citedreferenceStrong R, Miller RA, Astle CM, Floyd RA, Flurkey K, Hensley KL, Javors MA, Leeuwenburgh C, Nelson JF, Ongini E, Nadon NL, Warner HR, Harrison DE ( 2008 ) Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice. Aging Cell 7, 641 – 650.
dc.identifier.citedreferenceStrong R, Miller RA, Astle CM, Baur JA, de Cabo R, Fernandez E, Guo W, Javors M, Kirkland JL, Nelson JF, Sinclair DA, Teter B, Williams D, Zaveri N, Nadon NL, Harrison DE ( 2013 ) Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium‐chain triglyceride oil on life span of genetically heterogeneous mice. J. Gerontol. A Biol. Sci. Med. Sci. 68, 6 – 16.
dc.identifier.citedreferenceSykiotis GP, Bohmann D ( 2008 ) Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in Drosophila. Dev. Cell 14, 76 – 85.
dc.identifier.citedreferenceVelmurugan K, Alam J, McCord JM, Pugazhenthi S ( 2009 ) Synergistic induction of heme oxygenase‐1 by the components of the dietary supplement Protandim. Free Radical Biol. Med. 46, 430 – 440.
dc.identifier.citedreferenceWang C, Li Q, Redden DT, Weindruch R, Allison DB ( 2004 ) Statistical methods for testing effects on “maximum lifespan”. Mech. Ageing Dev. 125, 629 – 632.
dc.identifier.citedreferenceWitters LA ( 2001 ) The blooming of the French lilac. J. Clin. Invest. 108, 1105 – 1107.
dc.identifier.citedreferenceZhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk‐Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE ( 2001 ) Role of AMP‐activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167 – 1174.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
acel12496.pdf
Size:
1.178MB
Format:
PDF
View/Open
Name:
acel12496_am.pdf
Size:
941.4KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.